415 related articles for article (PubMed ID: 6373626)
1. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
Dhople AM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
[TBL] [Abstract][Full Text] [Related]
2. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
4. Primary and secondary dapsone resistance of M. leprae in Martinique, Guadeloupe, New Caledonia, Tahiti, Senegal, and Paris between 1980 and 1985.
Guelpa-Lauras CC; Cartel JL; Constant-Desportes M; Millan J; Bobin P; Guidi C; Brucker G; Flageul B; Guillaume JC; Pichet C
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):672-9. PubMed ID: 3323369
[TBL] [Abstract][Full Text] [Related]
5. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
Gupta UD; Katoch K; Natarajan M; Sharma VD; Sharma RK; Shivannavar CT; Katoch VM
Acta Leprol; 1997; 10(4):209-12. PubMed ID: 9447254
[TBL] [Abstract][Full Text] [Related]
6. Primary dapsone-resistant leprosy in San Francisco.
Gelber RH
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
[TBL] [Abstract][Full Text] [Related]
7. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu.
Sreevatsa ; Ramu G; Desikan KV
Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580
[TBL] [Abstract][Full Text] [Related]
9. Primary dapsone resistance in leprosy.
Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
[TBL] [Abstract][Full Text] [Related]
10. Application of ATP assay for in vitro drug screening testing against human derived M. leprae.
Katoch VM; Katoch K; Shivannavar CT; Sharma VD; Patil MA; Bharadwaj VP
Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179
[TBL] [Abstract][Full Text] [Related]
11. Secondary sulphone resistance in leprosy (Report of a case).
Lal S; Jaganath C; Garg BR; Paneerselvam R
Lepr India; 1980 Apr; 52(2):299-301. PubMed ID: 7005542
[TBL] [Abstract][Full Text] [Related]
12. Primary dapsone-resistant leprosy in Cebu, Philippines.
Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
[No Abstract] [Full Text] [Related]
14. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.
Gupta UD; Katoch K; Sharma RK; Singh HB; Natragan M; Singh D; Sharma VD; Chauhan DS; Das R; Srivastava K; Katoch VM
Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):328-34. PubMed ID: 12035294
[TBL] [Abstract][Full Text] [Related]
15. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
Gelber RH; Humphres RC; Fieldsteel AH
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
[TBL] [Abstract][Full Text] [Related]
16. Comparison of radiometric macrophage assay and the mouse foot pad infection for the evaluation of Mycobacterium leprae sensitivity/resistance to dapsone.
Sathish M; Rees RJ; Seshadri PS; Nath I
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):378-84. PubMed ID: 3900244
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of secondary dapsone resistance in Nepal.
Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB
Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344
[TBL] [Abstract][Full Text] [Related]
18. Clofazimine in the treatment of dapsone resistant leprosy.
Taylor PM; Alexander R
Lepr India; 1976 Oct; 48(4 Suppl):709-12. PubMed ID: 800234
[TBL] [Abstract][Full Text] [Related]
19. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
[TBL] [Abstract][Full Text] [Related]
20. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
